It is a pharma public limited company based in Delhi, Delhi, India, established in 2006.
2006 | Delhi, Delhi, India | ActiveMay And Baker Pharmaceuticals Limited, a active public limited company, was established on 23 January 2006 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U15400DL2006PLC145272. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Manju Bist (Director), Pooja Sharma (Director), Ritu Mirg (Director). Past directors included Allen Dass, Kusum Pal Sharma, Manju Bist. It holds no open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 11 May 2025, with the balance sheet filed on 31 March 2025. It is based at 301, 3Rd Floor, Laxmi Tower Lsc, Block- C, Saraswati Vihar, Delhi, Delhi, 110034.
U15400DL2006PLC145272
145272
23 January 2006
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into May And Baker Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Bist | Director | 02 Mar 2009 | Current |
| Pooja Sharma | Director | 15 May 2015 | Current |
| Ritu Mirg | Director | 02 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 May 2015 | Past |
| Pramod Abcsdd | Additional Director | 02 Mar 2009 | Past |
| Pramod Abcsdd | Additional Director | 11 Jul 2016 | Past |
| Pramod Abcsdd | Additional Director | 18 Mar 2008 | Past |
| Pramod Abcsdd | Whole-Time Director | 22 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 28 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
May And Baker Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.2% increase. The company also saw a substantial fall in profitability, with a 183.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, May And Baker Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2023 | Hdfc Bank Limited | ₹5.00 Cr | Satisfied |
| 19 May 2017 | Yes Bank Limited | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
May And Baker Pharmaceuticals has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of May And Baker Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped May And Baker Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity May And Baker Pharmaceuticals Limited last Annual general meeting of members was held on 11 May 2025 as per latest MCA records. was completed.
May And Baker Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge registered on 19 May 2017 via Charge ID 100101977 with Yes Bank Limited was fully satisfied on 15 Apr 2024. was documented.
The activity A charge registered on 22 Jun 2023 via Charge ID 100743628 with Hdfc Bank Limited was fully satisfied on 12 Jan 2024. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 100743628 was registered on 22 Jun 2023. was documented.
Progress on A charge with Yes Bank Limited amounted to Rs. 50.00 M with Charge ID 100101977 was registered on 19 May 2017. was documented.
The CIN of May And Baker Pharmaceuticals Limited is U15400DL2006PLC145272.
May And Baker Pharmaceuticals Limited is headquartered at 301, 3Rd Floor, Laxmi Tower Lsc, Block- C, Saraswati Vihar, Delhi, Delhi, 110034.
May And Baker Pharmaceuticals Limited was incorporated on 23 January 2006.
The current directors of May And Baker Pharmaceuticals Limited are
The primary industry of May And Baker Pharmaceuticals Limited is Hospital And Medical Care.
May And Baker Pharmaceuticals Limited is unlisted.
The authorized capital of May And Baker Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of May And Baker Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX